SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-004778
Filing Date
2024-02-02
Accepted
2024-02-02 16:39:06
Documents
14
Period of Report
2024-02-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39857
  Complete submission text file 0001493152-24-004778.txt   215499

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gnlx-20240202.xsd EX-101.SCH 3012
3 XBRL LABEL FILE gnlx-20240202_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE gnlx-20240202_pre.xml EX-101.PRE 22357
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3784
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Filer) CIK: 0001231457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41599 | Film No.: 24592178
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)